About ICON
ICON PLC (NASDAQ:ICLR) is a global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organizations. With its expertise in clinical development, the company focuses on advancing innovations from the lab to the market and particularly excels in the management of clinical trials across various therapeutic areas. ICON's projects range from large-scale global studies to localized trials, always prioritizing patient safety and data integrity. The company aims to enhance the efficiency of drug development, reduce costs, and accelerate the delivery of life-saving treatments to patients. Through strategic solutions and operational excellence, ICON strives to be a partner of choice in helping clients navigate the complexities of the healthcare landscape and achieve their scientific and commercial objectives.
Snapshot
Operations
Products and/or services of ICON
- Clinical Research Services - Full suite of clinical trial management, from study design to regulatory submission.
- Laboratory Services - Comprehensive central laboratory services including biomarker and genomic testing.
- Real-World Evidence - Collection and analysis of real-world data to support clinical and post-marketing studies.
- Patient Centric Services - Specialized programs designed to enhance patient engagement and trial participation.
- Consulting Services - Strategic advice on regulatory, product development, and market access strategies.
- Commercialisation & Outcomes - Services aimed at maximizing product reach and impact, including market access strategies, health economics, and outcomes research.
ICON executive team
- Dr. John Climax Ph.D.Founder & Independent Non-Executive Director
- Mr. Nigel Clerkin A.C.A.Chief Financial Officer
- Mr. Barry BalfeCEO & Director
- Mr. Thomas N. O'LearyChief Information Officer
- Mr. Diarmaid CunninghamChief Administrative Officer, General Counsel & Company Secretary
- Ms. Niamh MurphyDirector of Corporate Communications
- Mr. David GreenVice President of Marketing
- Mr. Joe CroninChief Human Resources Officer
- Mr. Simon HolmesPresident of Corporate Investments & Partnerships
- Dr. Gary CurtisSenior Vice President of Global Clinical Pharmacology